We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02963168
Recruitment Status : Unknown
Verified January 2019 by Athenex, Inc..
Recruitment status was:  Recruiting
First Posted : November 15, 2016
Last Update Posted : October 17, 2019
Information provided by (Responsible Party):
Athenex, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 30, 2020
Estimated Study Completion Date : April 30, 2020